Cidara Therapeutics Inc. (CDTX)
Cidara Therapeutics Max Pain By Strike
CDTX trades at $65.01, 62.5% above the near-term max pain of $40 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($35-$60), signaling increased put positioning or downside protection. Key magnetic zone at 60 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Cidara Therapeutics Max Pain By Expiry
Max pain for CDTX shows a downward trend from 60 to 35, indicating bearish sentiment or hedging activity. The 52% spread signals divergent expectations across timeframes. Most levels below 65.01 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 40 | -25.01 (-38.47%) |
| Sep 19, 2025 | 60 | -5.01 (-7.71%) |
| Oct 17, 2025 | 35 | -30.01 (-46.16%) |
| Nov 21, 2025 | 45 | -20.01 (-30.78%) |
| Feb 20, 2026 | 60 | -5.01 (-7.71%) |